February 11, 2009 5:48 PM
- Text
Menopause Therapy Sparks Controversy
(CBS)
Fifty-two-year old Glennis runs her house with brisk efficiency, but there was a time when her days were spent in a mind-numbing fog.
"I found myself very irritable, very tearful, everything would make me cry," Glennis explains.
Yes, it was menopause, CBS Evening News anchor Katie Couric reports.
"I was deteriorating into this old, nasty lady," she says, laughing. "I'd feel like I was outside my body looking at myself and my behavior and saying, 'Eww, do you have to be that way?'"
Glennis started taking synthetic hormones, but stopped when the study four years ago warned of the risks. Some experts believe the study was misinterpreted and that low levels of hormones taken over a short period of time are safe.
But many skeptical women turned to something called bioidenticals. These products, derived from soy and yam extracts, are structurally identical to those hormones found in a woman's body, but they are not approved by the FDA.
Dr. Erika Schwartz, author of four books about menopause, is an advocate for bioidenticals, prescribing them to others and herself.
"I have seen people get their sex drive back. I've seen women get rid of their hot flashes, their night sweats, re-capturing their ability to sleep," Dr. Schwartz says.
But critics say there's virtually no difference between bioidenticals and their synthetic counterparts. And now, doctors are concerned that a new bestseller by former actress Suzanne Somers is creating more hype and more confusion.
"These people are claiming that these are natural, that they don't increase the risk of breast cancer, That's absolute nonsense," says Dr. Wulf Utian, executive director of the North American Menopause Society. "They carry exactly the same risks and exactly the same potential benefits as the commercial products."
Critics also say the compounding pharmacies mixing the bioidenticals aren't regulated enough.
"If they're getting something that's mixed in the backroom of a pharmacy, then they're not certain what they're getting," Dr. Utian says.
But the issue, says Dr. Schwartz, isn't about safety. It's about dollars and cents. Since bioidenticals are found in nature and can't be patented, Schwartz says that drug companies have no financial incentive to study them.
"I have no doubt that it's about profit," Dr. Schwartz says, adding that she wants a long-term study on these plant-derived hormones. For now, these women say the relief they're getting from bioidenticals today is worth whatever they may face in the future.
"I'm more worried about the risks if I don't take this," Glennis says.
"It's really just about maybe the second half of your life and being able to get through that feeling as good as you possibly can," says Stacy Pear, another patient.
"I found myself very irritable, very tearful, everything would make me cry," Glennis explains.
Yes, it was menopause, CBS Evening News anchor Katie Couric reports.
"I was deteriorating into this old, nasty lady," she says, laughing. "I'd feel like I was outside my body looking at myself and my behavior and saying, 'Eww, do you have to be that way?'"
Glennis started taking synthetic hormones, but stopped when the study four years ago warned of the risks. Some experts believe the study was misinterpreted and that low levels of hormones taken over a short period of time are safe.
But many skeptical women turned to something called bioidenticals. These products, derived from soy and yam extracts, are structurally identical to those hormones found in a woman's body, but they are not approved by the FDA.
Dr. Erika Schwartz, author of four books about menopause, is an advocate for bioidenticals, prescribing them to others and herself.
"I have seen people get their sex drive back. I've seen women get rid of their hot flashes, their night sweats, re-capturing their ability to sleep," Dr. Schwartz says.
But critics say there's virtually no difference between bioidenticals and their synthetic counterparts. And now, doctors are concerned that a new bestseller by former actress Suzanne Somers is creating more hype and more confusion.
"These people are claiming that these are natural, that they don't increase the risk of breast cancer, That's absolute nonsense," says Dr. Wulf Utian, executive director of the North American Menopause Society. "They carry exactly the same risks and exactly the same potential benefits as the commercial products."
Critics also say the compounding pharmacies mixing the bioidenticals aren't regulated enough.
"If they're getting something that's mixed in the backroom of a pharmacy, then they're not certain what they're getting," Dr. Utian says.
But the issue, says Dr. Schwartz, isn't about safety. It's about dollars and cents. Since bioidenticals are found in nature and can't be patented, Schwartz says that drug companies have no financial incentive to study them.
"I have no doubt that it's about profit," Dr. Schwartz says, adding that she wants a long-term study on these plant-derived hormones. For now, these women say the relief they're getting from bioidenticals today is worth whatever they may face in the future.
"I'm more worried about the risks if I don't take this," Glennis says.
"It's really just about maybe the second half of your life and being able to get through that feeling as good as you possibly can," says Stacy Pear, another patient.
Latest Now in CBS Evening News
- Evening News Online, 02.09.12
- One mortgage mess culprit: Signature mills
- Remembering Kodak cameras
- Obama frees 10 states from "No Child Left Behind"
- Assad continues relentless attack on Homs
- Inside the job of a robo-signer
- Big banks, gov't officials strike $25B deal
- Civilians bear the brunt of Syrian assault
- Oral history of N. Ireland strife raises dilemma
- Repairman reminisces as Kodak retires its cameras
- Evening News Online, 02.08.12
- Female soldiers tell stories from the frontlines
- Behind winter's wild weather
- Gas prices continue to creep up
- GOP turns up heat on Obama contraceptive law
- Do Santorum wins signal fundamental change in GOP?
- Are Santorum wins good for GOP's future?
Latest CBS News Headlines
on Facebook
on CBS News
- Consumer sentiment highlights risks to recovery
- TV anchor recovering from dog bite during segment
- Private equity firm Apollo posts lower 4Q profit
- London to test alcohol monitors for offenders
on Facebook
- Tenn. father charged with murdering couple who"unfriended" daughter on Facebook
- Adele opens up about vocal cord surgery
on CBS News






